Financials SciSparc Ltd.

Equities

SPRC

IL0010951403

Pharmaceuticals

Market Closed - Nasdaq 04:00:00 2024-05-10 pm EDT 5-day change 1st Jan Change
1.25 USD -2.34% Intraday chart for SciSparc Ltd. -0.79% -74.39%

Valuation

Fiscal Period: December 2021 2022 2023
Capitalization 1 14.17 5.09 2.556
Enterprise Value (EV) 1 7.362 1.543 -2.444
P/E ratio -2.2 x -1.33 x -0.34 x
Yield - - -
Capitalization / Revenue - 3,779,071 x 887,821 x
EV / Revenue - 1,145,812 x -848,893 x
EV / EBITDA -1.28 x -0.19 x 0.46 x
EV / FCF -1.43 x -0.38 x 0.41 x
FCF Yield -69.9% -266% 242%
Price to Book 2.37 x 0.8 x 0.45 x
Nbr of stocks (in thousands) 87.5 259 524
Reference price 2 162.0 19.64 4.880
Announcement Date 4/28/22 5/1/23 4/1/24
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales - - - - 1.347 2.879
EBITDA 1 -9.142 -3.986 -2.387 -5.755 -8.1 -5.282
EBIT 1 -9.289 -4.108 -2.551 -5.768 -8.287 -5.773
Operating Margin - - - - -615.22% -200.52%
Earnings before Tax (EBT) 1 -9.009 -4.479 -3.535 -5.789 -2.578 -5.861
Net income 1 -8.523 -4.794 -3.482 -5.789 -2.592 -5.122
Net margin - - - - -192.43% -177.91%
EPS - - - -73.58 -14.82 -14.43
Free Cash Flow 1 -3.632 -3.688 -1.91 -5.145 -4.105 -5.923
FCF margin - - - - -304.78% -205.72%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 5/15/19 6/15/20 3/30/21 4/28/22 5/1/23 4/1/24
1USD in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 0.34 0.71 1.76 6.81 3.55 5
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 -3.63 -3.69 -1.91 -5.15 -4.11 -5.92
ROE (net income / shareholders' equity) -211% -9,844% -490% -121% -35.5% -73.4%
ROA (Net income/ Total Assets) -82.2% -89.9% -85.8% -57.8% -50.5% -33.1%
Assets 1 10.37 5.335 4.057 10.02 5.135 15.46
Book Value Per Share - - 35.90 68.50 24.70 10.80
Cash Flow per Share - - 48.80 57.80 13.70 2.940
Capex 1 0.02 0 - 0.04 0.01 -
Capex / Sales - - - - 0.59% -
Announcement Date 5/15/19 6/15/20 3/30/21 4/28/22 5/1/23 4/1/24
1USD in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. SPRC Stock
  4. Financials SciSparc Ltd.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW